Plasma Selenium, Manganese Superoxide Dismutase, and Intermediate- or High-Risk Prostate Cancer

PURPOSE: In vitro, in vivo, and epidemiologic studies support a role for selenium in reducing the risk of prostate cancer. Our group previously demonstrated a strong interaction between plasma selenium and the manganese superoxide dismutase (SOD2) gene and incident prostate cancer risk. We now hypot...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Chan, June M., Oh, William K., Xie, Wanling, Regan, Meredith M., Stampfer, Meir J., King, Irena B., Abe, Miyako, Kantoff, Philip W.
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2009
Assuntos:
Original Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2720077/
https://ncbi.nlm.nih.gov/pubmed/19528373
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.18.8938
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares